340 related articles for article (PubMed ID: 16054105)
1. Should chloroquine be laid to rest?
Ginsburg H
Acta Trop; 2005 Oct; 96(1):16-23. PubMed ID: 16054105
[TBL] [Abstract][Full Text] [Related]
2. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
3. Malaria. Chloroquine makes a comeback.
Vogel G
Science; 2006 Nov; 314(5801):904. PubMed ID: 17095662
[No Abstract] [Full Text] [Related]
4. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
Laufer MK; Plowe CV
Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Safeukui I; Mangou F; Malvy D; Vincendeau P; Mossalayi D; Haumont G; Vatan R; Olliaro P; Millet P
Biochem Pharmacol; 2004 Nov; 68(10):1903-10. PubMed ID: 15476661
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of serum of mice infected with chloroquine-resistant 'NS' line to the antimalarial action of chloroquine.
Li GD; Qian YL; Chen L
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):257-60. PubMed ID: 2692400
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
Ojurongbe O; Ogungbamigbe TO; Fagbenro-Beyioku AF; Fendel R; Kremsner PG; Kun JF
Malar J; 2007 Apr; 6():41. PubMed ID: 17428334
[TBL] [Abstract][Full Text] [Related]
8. [Malaria drug for African poor in sight].
Knauer RH
Fortschr Med; 1998 Mar; 116(7):12-4. PubMed ID: 9562711
[No Abstract] [Full Text] [Related]
9. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism.
He Z; Chen L; You J; Qin L; Chen X
Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial activity of methanolic extracts from plants used in Kenyan ethnomedicine and their interactions with chloroquine (CQ) against a CQ-tolerant rodent parasite, in mice.
Muregi FW; Ishih A; Miyase T; Suzuki T; Kino H; Amano T; Mkoji GM; Terada M
J Ethnopharmacol; 2007 Apr; 111(1):190-5. PubMed ID: 17145149
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment with chloroquine and parasite chloroquine resistance in Ghanaian children with severe malaria.
Evans JA; May J; Tominski D; Eggelte T; Marks F; Abruquah HH; Meyer CG; Timmann C; Agbenyega T; Horstmann RD
QJM; 2005 Nov; 98(11):789-96. PubMed ID: 16186171
[TBL] [Abstract][Full Text] [Related]
13. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Kolaczinski K; Durrani N; Rahim S; Rowland M
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis.
A-Elbasit IE; Elbashir MI; Khalil IF; Alifrangis M; Giha HA
Trop Med Int Health; 2006 May; 11(5):604-12. PubMed ID: 16640612
[TBL] [Abstract][Full Text] [Related]
15. Revising antimalarial drug policy in Central America: experience in Panama.
Calzada JE; Samudio F; Bayard V; Obaldia N; de Mosca IB; Pascale JM
Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):694-8. PubMed ID: 18436272
[TBL] [Abstract][Full Text] [Related]
16. Fitness costs of resistance to antimalarial drugs.
Felger I; Beck HP
Trends Parasitol; 2008 Aug; 24(8):331-3. PubMed ID: 18603474
[TBL] [Abstract][Full Text] [Related]
17. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum.
Sanchez CP; Stein WD; Lanzer M
Trends Parasitol; 2007 Jul; 23(7):332-9. PubMed ID: 17493873
[TBL] [Abstract][Full Text] [Related]
18. In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice.
Muregi FW; Ishih A; Suzuki T; Kino H; Amano T; Mkoji GM; Miyase T; Terada M
Phytother Res; 2007 Apr; 21(4):337-43. PubMed ID: 17221829
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
20. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea.
Lee KS; Kim TH; Kim ES; Lim HS; Yeom JS; Jun G; Park JW
Am J Trop Med Hyg; 2009 Feb; 80(2):215-7. PubMed ID: 19190216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
